Dividend Champion, Contender, And Challenger Highlights: Week October 4
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Stock Taper 
A
$169.09
▼ DOWN 0.14% (-0.24)
KEY STATISTICS
Market Cap$47.63 B
52w High$177.05
52w Low$108.35
Dividend Yield0.65%
FrequencyQuarterly
P/E29.10
Volume2.56M
Shares Out.282.43M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Padraig McDonnell
COMPENSATION 2026
Salary$1,141,345
Stock Awards$8,169,850
Incentive Plan Pay$1,436,809
All Other Comp.$61,473
Total$12,827,236
ABOUT
SECTOR
Healthcare
WENT PUBLIC
November 18, 1999
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
18,200
PRICE TARGET
Target High$195.00
Target Low$150.00
Target Median$173.50
Target Consensus$171.67
UPCOMING EARNINGS
DateNov 23, 2026
DayMonday
Rev. Est.$1.99B
NOV
23
MON
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2014-11-03 | Forward | 699:500 |
ETFS HOLDING THIS STOCK
ETFS HOLDING
977
LISTED HERE
10
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
48.97%
HOLDERS
1,715
TOP 8 OF 1,715 · RANKED BY POSITION SIZE
PRICE
$169.09 ▼ DOWN 0.14% (−$0.24)About Agilent Technologies, Inc.
https://www.agilent.com ↗Agilent Technologies provides advanced solutions and instruments for life sciences, diagnostics, and applied markets worldwide, including chromatography, mass spectrometry, genomics, lab automation, and related software and services.
INDUSTRY
Medical - Diagnostics & Research
A PRODUCT AGILENT TECHNOLOGIES, INC. IS KNOWN FOR
Agilent InfinityLab Pro iQ Series
The Agilent InfinityLab Pro iQ Series is a cutting-edge single quadrupole LC/MS system offering high precision and sensitivity for analyzing therapeutic molecules across pharmaceuticals, biotech, and research sectors.
Agilent Technologies in 2025
SENTIMENT: + POSITIVE
EARNINGS · NOVEMBER 24, 2025
Agilent Technologies Exceeds Q4 and Full-Year 2025 Earnings Expectations, Showcasing Strong Growth
Agilent Technologies reported robust financial results for its fourth quarter and full fiscal year 2025, ending October 31, 2025. The company surpassed its own revenue guidance and analyst expectations, with Q4 revenue reaching $1.86 billion, a 9.4% reported increase year-over-year, and full-year revenue hitting $6.95 billion. This strong performance, driven by significant growth in its Life Sciences and Diagnostics Markets Group, led to a positive market reaction and underscored the company's effective cost management and innovation strategy.
RESTRUCTURING · NOVEMBER 2024 · COMPLETED
Agilent Technologies Implements Major Organizational Restructuring to Enhance Market Focus and Customer-Centricity
Agilent Technologies executed a significant reorganization of its business segments in early 2025 to better align with its market-focused and customer-centric strategy. This strategic shift resulted in the formation of three new business groups: the Life Sciences and Diagnostics Markets Group (LDG), the Applied Markets Group (AMG), and the Agilent CrossLab Group (ACG). This new structure is intended to streamline operations, enhance collaboration, and accelerate growth by being more responsive to customer needs in specific end markets.
Latest News
EARLIER COVERAGE
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time.
A DCF Analysis: Intrinsic Value $120 vs Price $175
On September 30, 2026, we present a DCF analysis for Agilent Technologies Inc (A), a company that has shown robust price performance with a year-to-date increas
Agilent Technologies (NYSE:A) Hits New 52-Week High – What’s Next?
Shares of Agilent Technologies, Inc. (NYSE: A - Get Free Report) hit a new 52-week high during mid-day trading on Monday. The company traded as high as $174.77 and last traded at $174.67, with a volume of 488742 shares. The stock had previously closed at $172.79. Wall Street Analysts Forecast Growth A number of brokerages recently
RATINGS SNAPSHOT
Overall rating: B+
Discounted Cash Flow3
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book2
Overall Score3
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 7
OVERWEIGHT 4
OUTPERFORM 4
NEUTRAL 1
SECTOR WEIGHT 1
17 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 TMO | $661.57 | COMPARE |
 DHR | $217.66 | COMPARE |
 CAH | $228.30 | COMPARE |
 EW | $85.15 | COMPARE |
 BDX | $176.80 | COMPARE |
 WAT | $435.88 | COMPARE |
 IQV | $258.21 | COMPARE |
 ILMN | $276.52 | COMPARE |
TRADES BY CONGRESS
HOUSE TRADES
Ro Khanna
Sale
2026-01-29
Julie Johnson
Sale (Full)
2025-09-23
Lisa C. McClain
Sale (Full)
2025-07-16
Lisa McClain
Sale (Full)
2025-07-16
INSIDER TRADES
★
DIRECTOR
Boehnlein Glenn S
Purchase · 817 shares
2026-09-08
★
DIRECTOR
Boehnlein Glenn S
— · —
2026-09-04
★
DIRECTOR
Dolsten Mikael
Sale · 634 shares
2026-09-04
★
OFFICER: SENIOR VICE PRESIDENT
KIRKWOOD JONAH PREVOST
Sale · 30 shares
2026-06-26